Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy
Open Access
Abstract
No treatment has hitherto proved effective in PLCH. Tumour-like LCH has been reported to respond to cladribine (2-chlorodeoxyadenosine),2–4 a chemotherapeutic agent cytotoxic for lymphocyte and monocyte cells. Cladribine was also observed to have an effect in one case of tumour-like LCH involving the lung.5 One patient with PLCH improved after multiple treatments including cladribine, but the effect of this agent could not be clearly established.6 Whether cladribine as a single agent is effective in PLCH presenting as infiltrative lung disease is currently unknown. We report the effect of cladribine chemotherapy in one patient with PLCH presenting as infiltrative lung disease with progressive lung function impairment.Keywords
This publication has 9 references indexed in Scilit:
- Pleurodesis for malignant pleural effusion: talc, toxicity and where next?Thorax, 2008
- Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smokerRespiratory Medicine, 2008
- Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2‐chlorodeoxyadenosinePediatric Blood & Cancer, 2007
- Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort studyThe Lancet, 2007
- Who's (still) afraid of talc?European Respiratory Journal, 2007
- Randomized Trials Describing Lung Inflammation after Pleurodesis with Talc of Varying Particle SizeAmerican Journal of Respiratory and Critical Care Medicine, 2004
- 2-Chlorodeoxyadenosine Therapy for Disseminated Langerhans Cell HistiocytosisMayo Clinic Proceedings, 2003
- Successful treatment of Langerhans cell histiocytosis with 2‐chlorodeoxyadenosineRespirology, 2003
- Clinical Outcomes of Pulmonary Langerhans'-Cell Histiocytosis in AdultsNew England Journal of Medicine, 2002